Onset of psoriasis with immune checkpoint inhibitor therapy: A systematic review

To the Editor: The development of immune checkpoint inhibitors (ICIs) is a significant therapeutic advancement in medical oncology. However, adverse events of psoriasis onset were reported in small studies.1 This systematic review characterizes all reports of ICI-associated psoriasis to improve our understanding of the clinical implications.